| 1 | 1/1 | 返回列表 |
| 查看: 633 | 回復(fù): 0 | |||
ls_2018新蟲 (小有名氣)
|
[交流]
美國(guó)國(guó)立衛(wèi)生研究院(NIH)國(guó)家腫瘤中心(NCI)Chengkai Dai實(shí)驗(yàn)室招聘博后
|
|
美國(guó)國(guó)立衛(wèi)生研究院(NIH)國(guó)家腫瘤中心(NCI)Chengkai Dai實(shí)驗(yàn)室招聘博后 熱烈歡迎有興趣的同仁加入! Position Title: Elucidation of proteomic instability in cancer and the role of HSF1 in enabling oncogenesis. Position Description: Dr. Chengkai Dai’s laboratory at the Mouse Cancer Genetics Program (MCGP), National Cancer Institute (NCI), USA has one postdoctoral fellowship (visiting fellow) position open. The candidates will participate in projects that elucidate proteomic instability of cancer and tumor-associated amyloidogenesis, new phenomena in cancer biology, and investigate the multifaceted pro-oncogenic roles of heat shock factor 1 (HSF1). HSF1, the master transcriptional regulator of the heat-shock or proteotoxic stress, response, plays a critical role in preserving proteomic stability under stress conditions. Contrasting with its dispensability for primary cells, cancerous cells become dependent on HSF1, a phenomenon referred to as “non-oncogene addiction”. Revealed by Project Achilles, numerous human cancer cell lines depend on HSF1. Dr. Dai’s laboratory is conducting interdisciplinary research in the emerging field of proteomic instability of cancer. His recent research reveals that amyloidogenesis, due to disruption of proteome homeostasis, is tumor-suppressive and that HSF1 plays a critical role in repressing amyloidogenesis (Cell. 2015, 160:729-44; Nature Cell Biology. 2016, 18:527-39; Molecular Cell. 2019, 76:546-561; Science Advances. 2020, 6:eabc6871). Detailed information about Dr. Dai’s research and publications can be accessed at https://ccr.cancer.gov/staff-directory/chengkai-dai. Candidates for the postdoctoral fellowship may have up to 4 years of postdoctoral training experience. NCI offers an outstanding environment for training and career development. Postdoctoral trainees in Dr. Dai’s lab have successfully competed for NCI career transition awards and secured independent faculty positions. Applications, sent by e-mail to Dr. Dai (chengkai.dai@nih.gov), Phone (301) 846-5227, should consist of a cover letter describing research experience and interests, curriculum vitae, bibliography, and contact information of three references. Employer Name: Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, NIH, DHHS. Position Location: National Cancer Institute – Frederick, Frederick, MD 21702 These positions are subject to a background investigation. The NIH is dedicated to building a diverse community in its training and employment programs. |
| 1 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 314求調(diào)劑 +4 | 無(wú)懈可擊的巨人 2026-03-12 | 4/200 |
|
|---|---|---|---|---|
|
[考研] (081700)化學(xué)工程與技術(shù)-298分求調(diào)劑 +9 | 11啦啦啦 2026-03-11 | 9/450 |
|
|
[考研] 277求調(diào)劑 +3 | anchor17 2026-03-12 | 3/150 |
|
|
[考研] 307求調(diào)劑 +6 | 超級(jí)伊昂大王 2026-03-10 | 6/300 |
|
|
[考研] 調(diào)劑 +5 | 調(diào)劑的考研學(xué)生 2026-03-09 | 5/250 |
|
|
[考研] 2026考研求調(diào)劑-材料類-本科211一志愿985-初試301分 +10 | 蟲友233 2026-03-07 | 10/500 |
|
|
[考研] 材料專碩調(diào)劑 +7 | 慕辰123 2026-03-05 | 10/500 |
|
|
[考研]
|
likeihood 2026-03-06 | 16/800 |
|
|
[考博] 找博導(dǎo) +4 | 小呆呆熊 2026-03-07 | 4/200 |
|
|
[考研] 0703化學(xué)調(diào)劑 +7 | 小奶蒼 2026-03-07 | 7/350 |
|
|
[考研] 數(shù)二英二309分請(qǐng)求調(diào)劑 +3 | dtdxzxx 2026-03-09 | 4/200 |
|
|
[考研] 一志愿山東大學(xué),總分327,英語(yǔ)二79,有論文,有競(jìng)賽,已過(guò)四六級(jí) +3 | 木木目目1 2026-03-09 | 3/150 |
|
|
[考研] 296求調(diào)劑 +4 | Xinyu Wu311 2026-03-09 | 4/200 |
|
|
[考研] 070300化學(xué)求調(diào)劑292分 +3 | 打烊eee 2026-03-07 | 3/150 |
|
|
[考研] 第一志愿上海大學(xué),專業(yè)化學(xué)工程與技術(shù),總分288,求調(diào)劑 +3 | 1829197082 2026-03-07 | 3/150 |
|
|
[考研] 306求調(diào)劑 +7 | Bahati 2026-03-05 | 7/350 |
|
|
[考研] 哈爾濱理工大學(xué)2026年研究生調(diào)劑,材料科學(xué)與化學(xué)工程學(xué)院研究生調(diào)劑 +3 | xinliu866 2026-03-06 | 3/150 |
|
|
[考研]
|
zbcm_zbcm 2026-03-05 | 6/300 |
|
|
[考研] 不限學(xué)校專業(yè)的調(diào)劑同學(xué)看過(guò)來(lái) +5 | 啊擺啊擺 2026-03-05 | 9/450 |
|
|
[考研] 材料與化工354調(diào)劑 +4 | Lucy-xiao 2026-03-06 | 7/350 |
|